The pharmacological inhibition of MDMX by CEP1347 in wild-type p53 retinoblastoma cell lines, which overexpresses MDMX, leads to an increased p53 expression and activation of the p53 pathway [147]. This evidence concerns the gene MDM4 and retinoblastoma.